Anixa Biosciences's total assets for Q1 2024 were $25.37M, a decrease of -0.59% from the previous quarter. ANIX total liabilities were $1.77M for the fiscal quarter, a -17.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.